Publication Date: December 17, 2024 Published By: Health Cares Blog Article Link: https://www.healthcaresblog.com/neoncs-home-based-treatment-gives-control-back/ NeOnc Executive Team: (l-r) Patrick Walters, Dr. Thomas Chen, Amir Heshmatpour, Keithly Garnett Being diagnosed with a terminal illness can leave a person feeling powerless, stripped of their agency, and utterly out of control of their own lives. And for brain cancer patients — […]

Publication Date: December 2, 2024 Published By: Venture Beat Article Link: https://www.msn.com/en-us/health/other/the-man-behind-the-mission-dr-thomas-chen-s-vision-for-brain-cancer-treatment/ar-AA1srUnv NeOnc Executive Team: (l-r) Patrick Walters, Dr. Thomas Chen, Amir Heshmatpour, Keithly Garnett Cancer research has made huge strides in recent decades, but some kinds of cancer are still difficult to understand. Brain cancer is one of those, though Dr. Thomas Chen — […]

Publication Date: November 20, 2024 Published By: LA Business First Article Link: https://www.bizjournals.com/losangeles/news/2024/11/20/innovative-strategy-neoncs-bold-move-in-biotech.html Amir F. Heshmatpour and Dr. Thomas Chen Thanks to the incredible medical innovation seen in the last decade or so, biotech companies are proliferating like never before. Several major biotech company in recent memory has evolved in the same way. But as […]

Publication Date: November 11, 2024 Published By: Forbes Article Link: https://www.forbes.com/sites/katevitasek/2024/11/11/how-professors-can-foster-innovation-amongst-the-students-they-teach/ “If it’s your responsibility to mold the future’s greatest minds, make a conscious effort to create an environment in which innovation can flourish.” Creative, innovative thinking is key to success. In fact, research from McKinsey has found that the top 10% of companies see […]

Publication Date: October 16, 2024 Published By: Under 30 CEO Article Link: https://www.under30ceo.com/the-man-behind-the-mission-dr-thomas-chens-vision-for-brain-cancer-treatment/ NeOnc Executive Team: (l-r) Patrick Walters, Dr. Thomas Chen, Amir Heshmatpour, Keithly Garnett Cancer research has made huge strides in recent decades, but some kinds of cancer are still difficult to understand. Brain cancer is one of those, though Dr. Thomas Chen, […]

Publication Date: September 26, 2024 Published By: Pharmacy Times Article Link: https://www.pharmacytimes.com/view/pharmacy-focus—oncology-edition-advancing-brain-cancer-research-and-treatment Pharmacy Times’ Assistant Editor Kennedy Ferruggia sat down with Dr. Thomas Chen to discuss his work on NeOnc’s nasal delivery system for chemotherapeutics. In the podcast they examine how NeOnc, Inc. is developing innovative intranasal drug delivery methods to bypass the blood-brain barrier […]

Publication Date: September 8, 2024 Published By: El Decano De Guadalajara Article Link: https://eldecanodeguadalajara.com/ Ya sea que un medicamento para el cancer cerebral entre al cuerpo a traves de una aguja en el brazo o se trague, la barrera hematoencefalica se erige como un formidable ultimo obstaculo en el camino de la terapia hacia su […]

Publication Date: September 8, 2024 Published By: Med City News Article Link: https://medcitynews.com/2024/09/biotech-ipo-direct-listing-neonc-brain-cancer-glioblastoma-intranasal-poh/#:~:text=BioPharma-,A%20Biotech%20Going%20Through%20the%20Nose%20to%20Treat%20the%20Brain,intranasally%20administered%20brain%20cancer%20drug. NeOnc Technologies is preparing to go public via the less common path of a direct listing as it continues mid-stage testing of its intranasally administered brain cancer drug. Meanwhile, the mostly stagnant biotech IPO pipeline is showing new signs of life with […]

Publication Date: August 16, 2024 Published By: Investing.com Article Link: https://www.investing.com/ California-based NeOnc’s groundbreaking nasal spray technology, which uses the olfactory nerve pathway to deliver life-saving cancer drugs directly to the brain, has won the Drug Delivery Technology of the Year award, marking a significant advancement in cancer treatment. NeOnc Executive Team: (l-r) Pat Walters, […]

Publication Date: August 16, 2024 Published By: Pharma Tech Outlook Article Link: https://www.pharmatechoutlook.com/neonc Glioblastoma is recognized as the most aggressive form of brain cancer in adults, with an approximate survival duration of 15 to 18 months, even with the best available treatment. The critical hurdle hindering most medication from reaching the desired site of action […]